BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9841744)

  • 1. Genetic and biochemical screening for endocrine disease.
    Goretzki PE; Höppner W; Dotzenrath C; Clark OH; Simon D; Cupisti K; Schulte H; Röher HD
    World J Surg; 1998 Dec; 22(12):1202-7. PubMed ID: 9841744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple endocrine neoplasia: a clinical model for applying molecular genetic techniques].
    Wohllk N; Becker P; Véliz J; Pineda G
    Rev Med Chil; 2000 Jul; 128(7):791-800. PubMed ID: 11050843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited endocrinopathies: an update.
    Lewis CE; Yeh MW
    Mol Genet Metab; 2008 Jul; 94(3):271-82. PubMed ID: 18434223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II.
    Ledger GA; Khosla S; Lindor NM; Thibodeau SN; Gharib H
    Ann Intern Med; 1995 Jan; 122(2):118-24. PubMed ID: 7992986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.
    Vieira AE; Mello MP; Elias LL; Lau IF; Maciel LM; Moreira AC; Castro M
    Horm Metab Res; 2002 Apr; 34(4):202-6. PubMed ID: 11987030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].
    Sansó G; Domené HM; Iorcansky S; Barontini M
    Medicina (B Aires); 1998; 58(2):179-84. PubMed ID: 9706252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hereditary neuroendrocrine tumors. Multiple endocrine neoplasia type 1 and 2].
    Rinke A; Galan SR; Fendrich V; Kann PH; Bartsch DK; Gress TM
    Internist (Berl); 2012 Apr; 53(4):400-7. PubMed ID: 22388921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
    Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
    Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
    J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine neoplasia type 2 and sporadic medullary thyroid carcinoma: Turkish experience.
    Erdogan MF; Gursoy A
    Pediatr Endocrinol Rev; 2006 Aug; 3 Suppl 3():503-7. PubMed ID: 17551473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations.
    Kambouris M; Jackson CE; Feldman GL
    Hum Mutat; 1996; 8(1):64-70. PubMed ID: 8807338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medullary carcinoma of thyroid gland].
    Spinelli C; Galleri D; Calbo L; Palmeri R; Miccoli P; Melita P
    Chir Ital; 1997; 49(4-5):21-5. PubMed ID: 10392179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple endocrine neoplasia type 2; MEN 2].
    Matsuura K; Araki K
    Nihon Rinsho; 2000 Jul; 58(7):1437-41. PubMed ID: 10921320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
    Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
    J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and genetic profile of patients with medullary thyroid cancer treated in the Cancer Centre--Institute of Oncology in Warsaw].
    Czetwertyńska M; Kozłowicz-Gudzińska I; Stachlewska-Nasfeter E; Sromek M; Skasko E; Paszko Z
    Endokrynol Pol; 2006; 57(4):415-9. PubMed ID: 17006846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.
    O'Riordain DS; O'Brien T; Weaver AL; Gharib H; Hay ID; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1017-23. PubMed ID: 7985081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer genetics: multiple endocrine neoplasia type 2, non-medullary familial thyroid cancer, and familial syndromes associated with thyroid cancer.
    Richards ML
    Surg Oncol Clin N Am; 2009 Jan; 18(1):39-52, viii. PubMed ID: 19056041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.